Cargando…

Effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: A randomized study

BACKGROUND AND OBJECTIVES: The present study was designed to evaluate the effect of intravenous dexmedetomidine on spinal anesthesia with 0.5% of hyperbaric bupivacaine. MATERIALS AND METHODS: One hundred American Society of Anesthesiologists (ASA) physical status I/II patients undergoing elective s...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinesh, Chilkunda N., Sai Tej, N.A., Yatish, Bevinaguddaiah, Pujari, Vinayak S., Mohan Kumar, R.M., Mohan, Chadalawada V.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024677/
https://www.ncbi.nlm.nih.gov/pubmed/24843333
http://dx.doi.org/10.4103/1658-354X.130719
_version_ 1782316679205748736
author Dinesh, Chilkunda N.
Sai Tej, N.A.
Yatish, Bevinaguddaiah
Pujari, Vinayak S.
Mohan Kumar, R.M.
Mohan, Chadalawada V.R.
author_facet Dinesh, Chilkunda N.
Sai Tej, N.A.
Yatish, Bevinaguddaiah
Pujari, Vinayak S.
Mohan Kumar, R.M.
Mohan, Chadalawada V.R.
author_sort Dinesh, Chilkunda N.
collection PubMed
description BACKGROUND AND OBJECTIVES: The present study was designed to evaluate the effect of intravenous dexmedetomidine on spinal anesthesia with 0.5% of hyperbaric bupivacaine. MATERIALS AND METHODS: One hundred American Society of Anesthesiologists (ASA) physical status I/II patients undergoing elective surgeries under spinal anesthesia were randomized into two groups of 50 each. Immediately after subarachnoid block with 3 ml of 0.5% hyperbaric bupivacaine, patients in group D received a loading dose of 1 μg/kg of dexmedetomidine intravenously by infusion pump over 10 min followed by a maintenance dose of 0.5 μg/kg/h till the end of surgery, whereas patients in group C received an equivalent quantity of normal saline. RESULTS: The time taken for regression of motor blockade to modified Bromage scale 0 was significantly prolonged in group D (220.7 ± 16.5 min) compared to group C (131 ± 10.5 min) (P < 0.001). The level of sensory block was higher in group D (T 6.88 ± 1.1) than group C (T 7.66 ± 0.8) (P < 0.001). The duration for two-dermatomal regression of sensory blockade (137.4 ± 10.9 min vs. 102.8 ± 14.8 min) and the duration of sensory block (269.8 ± 20.7 min vs. 169.2 ± 12.1 min) were significantly prolonged in group D compared to group C (P < 0.001). Intraoperative Ramsay sedation scores were higher in group D (4.4 ± 0.7) compared to group C (2 ± 0.1) (P < 0.001). Higher proportion of patients in group D had bradycardia (33% vs. 4%) (P < 0.001), as compared to group C. The 24-h mean analgesic requirement was less and the time to first request for postoperative analgesic was prolonged in group D than in group C (P < 0.001). CONCLUSION: Intravenous dexmedetomidine significantly prolongs the duration of sensory and motor block of bupivacaine spinal anesthesia. The incidence of bradycardia is significantly higher when intravenous dexmedetomidine is used as an adjuvant to bupivacaine spinal anesthesia. Dexmedetomidine provides excellent intraoperative sedation and postoperative analgesia.
format Online
Article
Text
id pubmed-4024677
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-40246772014-05-19 Effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: A randomized study Dinesh, Chilkunda N. Sai Tej, N.A. Yatish, Bevinaguddaiah Pujari, Vinayak S. Mohan Kumar, R.M. Mohan, Chadalawada V.R. Saudi J Anaesth Original Article BACKGROUND AND OBJECTIVES: The present study was designed to evaluate the effect of intravenous dexmedetomidine on spinal anesthesia with 0.5% of hyperbaric bupivacaine. MATERIALS AND METHODS: One hundred American Society of Anesthesiologists (ASA) physical status I/II patients undergoing elective surgeries under spinal anesthesia were randomized into two groups of 50 each. Immediately after subarachnoid block with 3 ml of 0.5% hyperbaric bupivacaine, patients in group D received a loading dose of 1 μg/kg of dexmedetomidine intravenously by infusion pump over 10 min followed by a maintenance dose of 0.5 μg/kg/h till the end of surgery, whereas patients in group C received an equivalent quantity of normal saline. RESULTS: The time taken for regression of motor blockade to modified Bromage scale 0 was significantly prolonged in group D (220.7 ± 16.5 min) compared to group C (131 ± 10.5 min) (P < 0.001). The level of sensory block was higher in group D (T 6.88 ± 1.1) than group C (T 7.66 ± 0.8) (P < 0.001). The duration for two-dermatomal regression of sensory blockade (137.4 ± 10.9 min vs. 102.8 ± 14.8 min) and the duration of sensory block (269.8 ± 20.7 min vs. 169.2 ± 12.1 min) were significantly prolonged in group D compared to group C (P < 0.001). Intraoperative Ramsay sedation scores were higher in group D (4.4 ± 0.7) compared to group C (2 ± 0.1) (P < 0.001). Higher proportion of patients in group D had bradycardia (33% vs. 4%) (P < 0.001), as compared to group C. The 24-h mean analgesic requirement was less and the time to first request for postoperative analgesic was prolonged in group D than in group C (P < 0.001). CONCLUSION: Intravenous dexmedetomidine significantly prolongs the duration of sensory and motor block of bupivacaine spinal anesthesia. The incidence of bradycardia is significantly higher when intravenous dexmedetomidine is used as an adjuvant to bupivacaine spinal anesthesia. Dexmedetomidine provides excellent intraoperative sedation and postoperative analgesia. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4024677/ /pubmed/24843333 http://dx.doi.org/10.4103/1658-354X.130719 Text en Copyright: © Saudi Journal of Anaesthesia http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Dinesh, Chilkunda N.
Sai Tej, N.A.
Yatish, Bevinaguddaiah
Pujari, Vinayak S.
Mohan Kumar, R.M.
Mohan, Chadalawada V.R.
Effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: A randomized study
title Effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: A randomized study
title_full Effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: A randomized study
title_fullStr Effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: A randomized study
title_full_unstemmed Effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: A randomized study
title_short Effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: A randomized study
title_sort effects of intravenous dexmedetomidine on hyperbaric bupivacaine spinal anesthesia: a randomized study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4024677/
https://www.ncbi.nlm.nih.gov/pubmed/24843333
http://dx.doi.org/10.4103/1658-354X.130719
work_keys_str_mv AT dineshchilkundan effectsofintravenousdexmedetomidineonhyperbaricbupivacainespinalanesthesiaarandomizedstudy
AT saitejna effectsofintravenousdexmedetomidineonhyperbaricbupivacainespinalanesthesiaarandomizedstudy
AT yatishbevinaguddaiah effectsofintravenousdexmedetomidineonhyperbaricbupivacainespinalanesthesiaarandomizedstudy
AT pujarivinayaks effectsofintravenousdexmedetomidineonhyperbaricbupivacainespinalanesthesiaarandomizedstudy
AT mohankumarrm effectsofintravenousdexmedetomidineonhyperbaricbupivacainespinalanesthesiaarandomizedstudy
AT mohanchadalawadavr effectsofintravenousdexmedetomidineonhyperbaricbupivacainespinalanesthesiaarandomizedstudy